{{Rsnum
|rsid=11950646
|Gene=SLC23A1
|Chromosome=5
|position=139378785
|Orientation=plus
|GMAF=0.4027
|Gene_s=SLC23A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 38.1 | 53.1 | 8.8
| HCB | 8.0 | 40.9 | 51.1
| JPT | 17.7 | 43.4 | 38.9
| YRI | 0.0 | 4.1 | 95.9
| ASW | 8.8 | 26.3 | 64.9
| CHB | 8.0 | 40.9 | 51.1
| CHD | 5.5 | 36.7 | 57.8
| GIH | 23.8 | 53.5 | 22.8
| LWK | 0.0 | 8.2 | 91.8
| MEX | 48.3 | 36.2 | 15.5
| MKK | 1.3 | 39.1 | 59.6
| TSI | 29.4 | 52.9 | 17.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=23737080
|Title=Vitamin C transporter gene (SLC23A1 and SLC23A2) polymorphisms, plasma vitamin C levels, and gastric cancer risk in the EPIC cohort
|OA=1
}}

{{PMID Auto
|PMID=18636124
|Title=Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=19243932
|Title=Genetic variation in sodium-dependent ascorbic acid transporters and risk of gastric cancer in Poland.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}